PARP inhibitors show promise in preventing toxic accumulations of brain disease proteins in Penn research study UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE PHILADELPHIA – A class of cancer drugs called PARP inhibitors could be useful for treating and preventing brain disorders, including amyotrophic lateral sclerosis (ALS), also called Lou Gehrig’s disease, and some forms of...
Tag: <span>cancer drugs</span>
Post
Repurposing promising cancer drugs may lead to a new approach to treating tuberculosis
Promising experimental cancer chemotherapy drugs may help knock out another life-threatening disease: tuberculosis (TB). A new study published by scientists at Texas Biomedical ResearchInstitute in San Antonio pinpoints a mechanism in regulating cell death called apoptosis that is a potential new target for helping to control the bacterial infection (Mycobacterium tuberculosis or M.tb) that causes the...
Post
Programming DNA to deliver cancer drugs
New technology could lead to the development of new cancer therapies DNA has an important job–it tells your cells which proteins to make. Now, a research team at the University of Delaware has developed technology to program strands of DNA into switches that turn proteins on and off. UD’s Wilfred Chen Group describes their results...
Post
New cancer drugs turn patients’ gray hair BROWN in bizarre side effect that has left scientists baffled
A Spanish study analyzed 52 patients taking immunotherapy drugs They found the drugs turn gray hair dark in 14 of the lung cancer patients In one patient, their hair even turned completely black in patches Cancer patients’ gray hair unexpectedly turned dark while taking new immunotherapy drugs, a new study reveals. While chemotherapy is notorious...